86.90.E - Healthcare
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
62.01.Z - Activities related to programming, IT consulting, and related activities
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
72.20.Z - Scientific research and development in social sciences and humanities
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
85.60.Z - Educational support activities
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 7 | -0 | -100,6 |
EBITDA | 7 | -0 | -100,6 |
Short time liabilities | 0,6 | 0,7 | 1,9 |
Equity capital | 6,4 | 6,3 | -0,7 |
Operating profit (EBIT) | 7 | -0 | -100,6 |
Assets | 8 | 8 | -0,3 |
Net profit (loss) | 6,4 | -0 | -100,7 |
Cash | 0 | 0 | -65,9 |
Net income from sale | 7,1 | 0 | -100 |
Liabilities and provisions for liabilities | 1,6 | 1,7 | 1,4 |
Working assets | 0 | 0 | -65,9 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | 100 | -0,7 | -100,7 |
Equity capital to total assets | 79,4 | 79,1 | -0,3 |
Gross profit margin | 98,7 | ||
EBITDA Margin | 98,7 | ||
Days | Days | Days | |
Short term commitment turnover cycle | 33 | 2 147 483 648 | 2 147 483 615 |
Current financial liquidity indicator | 0.0013561761006712914 | 0.0004533784813247621 | 0 |
Net dept to EBITDA | 0.14260733127593994 | -23.520753860473633 | -23,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane